𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Predictive models for diagnosis of pleural effusions secondary to tuberculosis or cancer

✍ Scribed by Roberta K.B. SALES; Francisco S. VARGAS; Vera Luiza CAPELOZZI; Márcia SEISCENTO; Eduardo H. GENOFRE; Lisete R. TEIXEIRA; Leila ANTONANGELO

Book ID
108965170
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
133 KB
Volume
14
Category
Article
ISSN
1323-7799

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intrapleural talc for the treatment of m
Intrapleural talc for the treatment of malignant pleural effusions secondary to breast cancer
✍ Ribas C. Milanez; Francisco S. Vargas; Luiz B. Filomeno; Lisete R. Teixeira; Ang 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 448 KB 👁 2 views

Background. The management of malignant pleural effusions secondary to breast cancer is a difficult problem. In the 1980s tetracycline was probably the most commonly used sclerosing agent, but parenteral tetracycline is no longer available. Therefore, it is important to evaluate alternative sclerosi

A comparative trial of LC9018 plus doxor
A comparative trial of LC9018 plus doxorubicin and doxorubicin alone for the treatment of malignant pleural effusion secondary to lung cancer
✍ Tomiya Masuno; Susumu Kishimoto; Takeshi Ogura; Takeshi Honma; Hisanobu Niitani; 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 565 KB

The efficacy and safety of intrapleural LC9018 (Yakult Co. Ltd., Tokyo, Japan) with or without doxorubicin (Adriamycin; Adria Laboratories, Columbus, OH) were evaluated in a randomized, controlled trial performed in 95 patients with malignant pleural effusions secondary to lung cancer. Seventy-six p